Literature DB >> 17369466

Abolition of reperfusion-induced arrhythmias in hearts from thiamine-deficient rats.

Fernando A Oliveira1, Silvia Guatimosim, Carlos H Castro, Diogo T Galan, Sandra Lauton-Santos, Angela M Ribeiro, Alvair P Almeida, Jader S Cruz.   

Abstract

Extensive work has been done regarding the impact of thiamine deprivation on the nervous system. In cardiac tissue, chronic thiamine deficiency is described to cause changes in the myocardium that can be associated with arrhythmias. However, compared with the brain, very little is known about the effects of thiamine deficiency on the heart. Thus this study was undertaken to explore whether thiamine deprivation has a role in cardiac arrhythmogenesis. We examined hearts isolated from thiamine-deprived and control rats. We measured heart rate, diastolic and systolic tension, and contraction and relaxation rates. Whole cell voltage clamp was performed in rat isolated cardiac myocytes to measure L-type Ca(2+) current. In addition, we investigated the global intracellular calcium transients by using confocal microscopy in the line-scan mode. The hearts from thiamine-deficient rats did not degenerate into ventricular fibrillation during 30 min of reperfusion after 15 min of coronary occlusion. The antiarrhythmogenic effects were characterized by the arrhythmia severity index. Our results suggest that hearts from thiamine-deficient rats did not experience irreversible arrhythmias. There was no change in L-type Ca(2+) current density. Inactivation kinetics of this current in Ca(2+)-buffered cells was retarded in thiamine-deficient cardiac myocytes. The global Ca(2+) release was significantly reduced in thiamine-deficient cardiac myocytes. The amplitude of caffeine-releasable Ca(2+) was lower in thiamine-deficient myocytes. In summary, we have found that thiamine deprivation attenuates the incidence and severity of postischemic arrhythmias, possibly through a mechanism involving a decrease in global Ca(2+) release.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369466     DOI: 10.1152/ajpheart.00833.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Right ventricular dysfunction in thiamine-responsive megaloblastic anaemia syndrome: a case report.

Authors:  Sedigheh Saedi; Majid Maleki; Sepideh Pezeshki
Journal:  Heart Asia       Date:  2011-01-01

2.  Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.

Authors:  Aline Lara; Denis D Damasceno; Rita Pires; Robert Gros; Enéas R Gomes; Mariana Gavioli; Ricardo F Lima; Diogo Guimarães; Patricia Lima; Carlos Roberto Bueno; Anilton Vasconcelos; Danilo Roman-Campos; Cristiane A S Menezes; Raquel A Sirvente; Vera M Salemi; Charles Mady; Marc G Caron; Anderson J Ferreira; Patricia C Brum; Rodrigo R Resende; Jader S Cruz; Marcus Vinicius Gomez; Vania F Prado; Alvair P de Almeida; Marco A M Prado; Silvia Guatimosim
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

3.  Cardiac beriberi: morphological findings in two fatal cases.

Authors:  Stefania Bello; Margherita Neri; Irene Riezzo; Mohammad Shafie Othman; Emanuela Turillazzi; Vittorio Fineschi
Journal:  Diagn Pathol       Date:  2011-01-19       Impact factor: 2.644

4.  Electrical properties of isolated cardiomyocytes in a rat model of thiamine deficiency.

Authors:  Artur Santos-Miranda; Jader Santos Cruz; Danilo Roman-Campos
Journal:  Arq Bras Cardiol       Date:  2015-03-01       Impact factor: 2.000

5.  Shoshin beriberi-thiamine responsive pulmonary hypertension in exclusively breastfed infants: A study from northern India.

Authors:  Javeed Iqbal Bhat; Hilal Ahmad Rather; Ambreen Ali Ahangar; Umar Amin Qureshi; Parvez Dar; Qazi Iqbal Ahmed; Bashir Ahmed Charoo; Syed Wajid Ali
Journal:  Indian Heart J       Date:  2016-08-02

6.  Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function.

Authors:  Andrezza M Barbosa; José F Sarmento-Neto; José E R Menezes Filho; Itamar C G Jesus; Diego S Souza; Valério M N Vasconcelos; Fagner D L Gomes; Aline Lara; Juliana S S Araújo; Sandra S Mattos; Carla M L Vasconcelos; Silvia Guatimosim; Jader S Cruz; Ines Batinic-Haberle; Demetrius A M Araújo; Júlio S Rebouças; Enéas R Gomes
Journal:  Oxid Med Cell Longev       Date:  2020-03-21       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.